- Messages
- 12
Talking at the Treating Autism Conference 2012 (www.treatingautism.co.uk), Dr Bradstreet explains how he made the connection between HIV patients, GcMAF and autism, and how he uses GcMAF from First Immune . He has checked the process and quality control and describes their laboratory as a boutique laboratory. He satisfies himself as to the quality, sterility and activity of the GcMAF and this has also confirmed by Prof Ruggerio in Italy. His medical paper is currently under peer review and will be published as soon as this process is completed. This describes how the presence of nagalase creates a reduction of naturally occurring GcMAF and observed reduction of nagalase from injectable GcMAF. He then goes on to describe the levels of success he is seeing in the treatment of autism using First Immune GcMAF
Extract and full version are available to view here:
Google gcmaf dot eu Dr Bradstreet at the Treating Autism Conference 9th September 2012
Extract and full version are available to view here:
Google gcmaf dot eu Dr Bradstreet at the Treating Autism Conference 9th September 2012